Novavax, Inc. (NASDAQ:NVAX) persists its position slightly strong in context of buying side, while shares price shows upbeat performance surged 4.87% during latest trading session. The firm has price volatility of 14.85% for a week and 9.05% for a month. Its beta stands at 1.50 times. . Narrow down four to firm performance, its weekly performance was 75.19% and monthly performance was -67.67%. The stock price of NVAX is moving down from its 20 days moving average with -58.76% and isolated negatively from 50 days moving average with -64.57%.
Narrow down focus to other ratios, the co has current ratio of 5.10 that indicates if NVAX lies in 1.3% to 3% then it is acceptable for both active and passive investors, but sometimes its varies industry to industry. Generally, it indicates good short-term financial strength. Street is more conscious on this after SunEdison, Inc. case. To make strengthen these views, the active industry firm has Quick Ratio of 5.10, which indicates firm has sufficient short-term assets to cover its immediate liabilities. In addition, the firm has debt to equity ratio of 2.87, sometimes its remain same with long term debt to equity ratio.
Following previous ticker characteristics, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) also run on active notice, stock price jumped up 1.71% after traded at $58.82 in most recent trading session.
SRPT price to current year EPS stands at -53.40%. Whereas the traders who further want to see about this, may be interested to see Price to next year’s EPS that would be 64.70%. Moving toward ratio analysis, it has current ratio of 2.30 and quick ratio was calculated as 2.30. The debt to equity ratio appeared as 0.17 for seeing its liquidity position.
Taking notice on volatility measures, price volatility of stock was 26.28% for a week and 10.54% for a month. The price volatility’s Average True Range for 14 days was 4.11. On these bases, analysts would recommend this stock as an “Active Revolving Stocks.” The firm attains analyst recommendation of 1.80 out of 1-5 scale with week’s performance of 105.44%. SRPT’s institutional ownership was registered as 72.70%, while insider ownership was 0.30%.